跳至主要内容
临床试验/IRCT201107187049N1
IRCT201107187049N1已完成3 期

An assessment of effects of melatonin on metabolic effects of olanzapine in patients with schizophrenia

Guilan University of Medical ScienceS0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Inclusion Criteria: age 18-65 year?diagnosis of schizophrenia based on DSM-IV-TR? capability to take drugs at 9.00 pm
  • Exclusion criteria: married women who are at reproductive age; history of drug abuse or dependence in the recent 30 days;history of taking olanzapine in the recent 3 months;history of allergy or intolerance to olanzapine; history of significant head trauma ( causing loss of concioussness more than 5 minutes or neurolgical or cognitive sequels);liver, kidney, cerebrovascular or cardiovascular disease;diabetes;metabolic syndrome; cancer ;using antiepileptic , antihypertensive or anticoagulant or anti-platelet drugs; using inhibitors or stimulants of hepatic isoenzymes that metabolize melatonin or olanzapine (e.g. omeprazole. rifampin, fluvuxamine, ciprofloxacin, carbamazepine, and modafinil) ; patients develop diabetes; acidosis; severe anticholinergic side effects; delirium or need for administration of another drug

排除标准

  • 未提供

研究者

发起方
Guilan University of Medical ScienceS

相似试验

An assessment of effects of melatonin on metabolic... | 临床试验